Latest JudgementCompetition Act, 2002

Competition Commission of India v. Monsanto Holdings Private Limited & connected matters, 2025

The Supreme Court did not address the core legal issue whether CCI can investigate SEP/patent-related antitrust matters but left the door open for the issue to be litigated again.

Supreme Court of India·23 September 2025
Competition Commission of India v. Monsanto Holdings Private Limited & connected matters, 2025
Competition Act, 2002
Share:

Judgement Details

Court

Supreme Court of India

Date of Decision

23 September 2025

Judges

Justice J.B. Pardiwala and Justice Sandeep Mehta

Citation

Acts / Provisions

Section 13(1)(ia), Hindu Marriage Act, 1955

Section 25, Hindu Marriage Act, 1955

Facts of the Case

  • CCI had initiated investigations against Ericsson and Monsanto based on complaints from Micromax, Intex, iBall, and others.

  • Ericsson: Imposing unfair licensing conditions related to Standard Essential Patents (SEPs) in telecom technology.

  • Monsanto: Charging excessive royalties for Bt cotton seed technology and not making patents reasonably accessible.

  • The Delhi High Court, in a judgment dated July 13, 2023, quashed the CCI investigations.

  • It ruled that the Patents Act, being a special law, overrides the Competition Act in matters involving patent licensing and abuse.

  • CCI challenged this decision in the Supreme Court via Special Leave Petitions (SLPs).

Issues

  1. Whether the CCI has jurisdiction to investigate anti-competitive practices involving patent rights?

  2. Whether the Competition Act can apply concurrently with the Patents Act in cases involving licensing abuse?

  3. Whether the settlement between the informants and the patent holders (Ericsson/Monsanto) renders CCI proceedings infructuous?

  4. Whether the Delhi High Court was right in quashing the CCI’s investigation based on statutory overlap?

Held

  • The SLPs was dismissed i.e. Delhi HC judgment upheld on account of settlement.

  • There is no ruling made on the jurisdictional conflict between the Competition Act and the Patents Act.

  • The Questions of law remain open for adjudication in future proceedings.

Analysis

  • The Supreme Court did not address the core legal issue whether CCI can investigate SEP/patent-related antitrust matters but left the door open for the issue to be litigated again.

  • The decision reflects a procedural resolution (settlement-induced mootness), not a substantive resolution of competition law vs patent law interplay.

  • The Delhi HC judgment, however, does have persuasive value and could influence lower forums until the Supreme Court definitively addresses the issue.

  • The HC's reasoning that the Patents Act is a special statute governing patent licensing—suggests that CCI’s jurisdiction may be ousted where the matter falls squarely within the Patents Act.

  • However, this narrow interpretation of CCI’s jurisdiction may have far-reaching implications for future antitrust enforcement in IP-heavy sectors, especially tech and biotech.

  • The Supreme Court’s decision not to settle the law could lead to forum shopping, regulatory gaps, and uncertainty until resolved in another case.